GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) » Definitions » Short-Term Debt & Capital Lease Obligation

Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Short-Term Debt & Capital Lease Obligation : ¥3,360 Mil (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Zhejiang Hisun Pharmaceutical Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Zhejiang Hisun Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥3,360 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Zhejiang Hisun Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥1,325 Mil.


Zhejiang Hisun Pharmaceutical Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Zhejiang Hisun Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisun Pharmaceutical Co Short-Term Debt & Capital Lease Obligation Chart

Zhejiang Hisun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,943.02 7,090.36 4,832.13 3,038.94 3,294.45

Zhejiang Hisun Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,413.09 3,294.45 3,731.99 3,498.72 3,360.18

Zhejiang Hisun Pharmaceutical Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Zhejiang Hisun Pharmaceutical Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisun Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Hisun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Executives
Yu Shun Bing Supervisors
Jin Hong Shun senior management
Lu Xing Hai senior management
Zhang Zhen Ying senior management
Jiang Guo Ping Director
Yang Zhi Qing senior management
Du Jia Qiu senior management
Chen Xiao Hua Directors, senior managers
Li Yan Directors, senior managers
Zhao Lei senior management
Shen Xi Fei Director
Zhang Wei senior management
Bai Hua Director
Chen Li Fei Supervisors
Hu Liang Bin senior management

Zhejiang Hisun Pharmaceutical Co Headlines

No Headlines